(1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen

C41H59F2N5O9S — CID 144710457

IUPAC(1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen
SMILESCOc1ccc2cc3c(nc2c1)O[C@@H]1C[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C4CC4)C[C@H]2C(F)F)N(C1)C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1CC[C@H](C)[C@H]1CCCCC3.[H][H].[H][H]
InChIInChI=1S/C41H55F2N5O9S.2H2/c1-22-11-16-32-28(22)10-8-6-7-9-24-17-23-12-13-25(55-5)18-30(23)44-36(24)56-26-19-31(48(21-26)37(50)33(40(2,3)4)45-39(52)57-32)35(49)46-41(20-29(41)34(42)43)38(51)47-58(53,54)27-14-15-27;;/h12-13,17-18,22,26-29,31-34H,6-11,14-16,19-21H2,1-5H3,(H,45,52)(H,46,49)(H,47,51);2*1H/t22-,26+,28+,29-,31-,32+,33+,41+;;/m0../s1
InChIKeyLGSLEDLZZIJRFM-LMTZMZOPSA-N
MW836.01 g/mol
LogP5.50
Rot. Bonds7

About (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen

(1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen (PubChem CID 144710457) has the molecular formula C41H59F2N5O9S and a molecular weight of 836.01 g/mol. Its IUPAC name is (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen.

Molecular Properties

Compound Name(1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen
PubChem CID144710457
Molecular FormulaC41H59F2N5O9S
Molecular Weight836.01 g/mol
Exact Mass835.40
IUPAC Name(1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen
SMILESCOc1ccc2cc3c(nc2c1)O[C@@H]1C[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C4CC4)C[C@H]2C(F)F)N(C1)C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1CC[C@H](C)[C@H]1CCCCC3.[H][H].[H][H]
InChIInChI=1S/C41H55F2N5O9S.2H2/c1-22-11-16-32-28(22)10-8-6-7-9-24-17-23-12-13-25(55-5)18-30(23)44-36(24)56-26-19-31(48(21-26)37(50)33(40(2,3)4)45-39(52)57-32)35(49)46-41(20-29(41)34(42)43)38(51)47-58(53,54)27-14-15-27;;/h12-13,17-18,22,26-29,31-34H,6-11,14-16,19-21H2,1-5H3,(H,45,52)(H,46,49)(H,47,51);2*1H/t22-,26+,28+,29-,31-,32+,33+,41+;;/m0../s1
InChIKeyLGSLEDLZZIJRFM-LMTZMZOPSA-N
XLogP5.50
TPSA182.33 Ų
H-Bond Donors3
H-Bond Acceptors10
Rotatable Bonds7
Heavy Atoms58
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500836.01
LogP ≤ 55.50
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1010

Analyze (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen?
The IUPAC name of (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen (CID 144710457) is (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen.
What is the SMILES notation for (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen?
The canonical SMILES for (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen is COc1ccc2cc3c(nc2c1)O[C@@H]1C[C@@H](C(=O)N[C@]2(C(=O)NS(=O)(=O)C4CC4)C[C@H]2C(F)F)N(C1)C(=O)[C@H](C(C)(C)C)NC(=O)O[C@@H]1CC[C@H](C)[C@H]1CCCCC3.[H][H].[H][H].
What is the InChIKey of (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen?
The InChIKey is LGSLEDLZZIJRFM-LMTZMZOPSA-N. The full InChI is InChI=1S/C41H55F2N5O9S.2H2/c1-22-11-16-32-28(22)10-8-6-7-9-24-17-23-12-13-25(55-5)18-30(23)44-36(24)56-26-19-31(48(21-26)37(50)33(40(2,3)4)45-39(52)57-32)35(49)46-41(20-29(41)34(42)43)38(51)47-58(53,54)27-14-15-27;;/h12-13,17-18,22,26-29,31-34H,6-11,14-16,19-21H2,1-5H3,(H,45,52)(H,46,49)(H,47,51);2*1H/t22-,26+,28+,29-,31-,32+,33+,41+;;/m0../s1.
What are the key properties of (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen?
(1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen has a molecular weight of 836.01 g/mol, XLogP of 5.50, 7 rotatable bonds, 3 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for (1R,18R,19S,22R,26S,29S)-26-tert-butyl-N-[(1R,2R)-1-(cyclopropylsulfonylcarbamoyl)-2-(difluoromethyl)cyclopropyl]-7-methoxy-19-methyl-24,27-dioxo-2,23-dioxa-4,25,28-triazapentacyclo[26.2.1.03,12.05,10.018,22]hentriaconta-3(12),4,6,8,10-pentaene-29-carboxamide;molecular hydrogen is sourced from PubChem (CID 144710457), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).